Phenogenetic map created for stem cell models of neurological diseases
Researchers have performed meta-analysis of neurological and neurodegenerative diseases and created an atlas of how cell characteristics are linked to their genotype...
List view / Grid view
Researchers have performed meta-analysis of neurological and neurodegenerative diseases and created an atlas of how cell characteristics are linked to their genotype...
Biological engineers identify genes that protect against protein linked to Parkinson's disease...
Drug Target Review welcomes Janusz Kulagowski to its advisory board ...
Researchers have identified the first case of a patient with Parkinson's disease carrying a mutation in the ACMSD gene...
Researchers have revealed the molecular mechanism behind a rare mutation has been associated with numerous neurodegenerative diseases...
Antibody targets thought to cause the most damage in neurological disorders, creates potential for a unified treatment approach...
T cells may play an important role in Parkinson’s disease (PD), according to a new study...
Researchers have developed a molecular compound that improves balance and coordination in mice with early stage Parkinson's disease.
A study has found that abnormal proteins found in Alzheimer's disease, Parkinson's disease, and Huntington's disease all share a ability to cause damage...
People with certain forms of early-onset Parkinson’s disease could potentially benefit from taking a medication used to treat certain forms of cancer.
Using flies, mice and patient cells, the team focused on cardiolipin, a fat unique to cells’ mitochondria, organelles that produce energy.
Neurodegenerative diseases such as Alzheimer’s disease and Parkinson’s disease are a global health, economic and social emergency.
31 October 2016 | By Niamh Louise Marriott, Digital Content Producer
"In our preclinical assessments of stem cell-derived dopamine neurons we noticed that the outcome in animal models varied dramatically, even though...
6 October 2016 | By Niamh Louise Marriott, Digital Content Producer
The grant from the MJFF therapeutic pipeline program will support studies for the optimisation of molecules to provide preclinical proof of concept in...
29 July 2016 | By Mandy Parrett, Editorial Assistant
Scientists have developed a new method of measuring the activity of disease-causing mutations in the LRRK2 gene, a major cause of inherited Parkinson’s disease.